Results of outpatient cardiac rehabilitation with the includion of physical training in patients after acute coronary syndrome  with a yearly follow-up

Main Article Content

L. M. Babii
V. O. Shumakov
N. M. Tereshchenko
Yu. Yu. Kovalchuk
O. P. Pogurelska
O. V. Voloshina
T. V. Talaieva
I. V. Tretyak

Abstract

The aim – to evaluate the results of clinical, instrumental and laboratory indicators, including the level of PCSK9, before and after physical activity with a symptom-limited test on a bicycle ergometer in patients after acute coronary syndrome (ACS) / myocardial infarction (MI) and ACS / unstable angina (UA) and interventional interventions on coronary vessels, as well as outpatient cardiac rehabilitation with the involvement of physical training in dynamics during 1 year of observation.
Materials and methods. The study included 101 patients (all men) with ACS/STEMI and ACS/US (unstable angina) aged 28 to 77 years (Me age was 56 (quartile 50–65) years). All patients underwent coronary angiography. 74 patients underwent urgent stenting of the infarct-causing artery, 16 – delayed stenting, 8 patients – coronary angioplasty, 5 patients with multivessel disease – coronary artery bypass grafting. All patients were divided into two groups using the «envelope method»: the 1st group (20 people) – patients included in the physical training program (PT), which was carried out in an outpatient setting, on a bicycle ergometer and was carried out for 2-2.5 months – a total of 24–30 sessions, and the 2nd group of 81 patients was the control group. Patients of the 2nd group underwent rehabilitation without PT in outpatient conditions with the inclusion of a complex kinesiotherapy and distance walking, recommended upon discharge from the hospital. All patients were observed for a year, three times a year (10–12 days from the development of ACS, after 3 months and after 12 months) were performed: symptom-limited test on a bicycle ergometer, echocardiography, biochemical studies, including a lipidogram, as well as determination of the level of PCSK9 before and after physical exertion on a bicycle ergometer.
Results and discussion. Patients after the physical trainig during the symptom-limited test 3 months after ACS (acute coronary syndrome) demonstrated a higher level of work performed (A) (45 kJ vs 27 kJ, p=0.000064) and better hemodynamic support for its performance (∆PD/A – 2.13 un. in the PT group vs 2.54 un. in the control group (p=0.034263)) and a greater increase in LV EF (56 % in the PT group vs 53 % in the control group, p=0.036793), with the results maintained for a year. During three visits, only patients in group 1 (PT) had a statistically significant decrease in PCSK9 levels after the exercise test (ET) (from 405 to 353 ng/ml, p=0.035693 after 3 months, and from 372 to 312 ng/ml, p=0.027993 after a year), compared with patients in the control group (from 240 to 225 ng/ml, p=0.60018 – after 3 months and from 332 to 296 ng/ml, p=0.224917). The obtained data indicate the effectiveness of outpatient cardiac rehabilitation of patients after ACS with the inclusion of physical training and demonstrate a decrease in PCSK9 levels, which is considered an independent factor in the progression of atherosclerosis.
Conclusions. The outpatient cardiac rehabilitation program with the inclusion of PT sessions on a bicycle ergometer for 2–2.5 months in patients after ACS contributed to a better restoration of tolerance to physical activity, an increase in LV EF. It was determined that only in the physical training group was a statistically significant decrease in the level of PCSK9 observed during the exercise test, which indicates one of the mechanisms of the positive effect of physical training on the process of preventing the progression of coronary atherosclerosis.

Article Details

Keywords:

acute coronary syndrome, coronary angiography, coronary artery stenting, symptom-limited exercise test on a bicycle ergometer, outpatient cardiac rehabilitation, exercise training on a bicycle ergometer, PCSK9 level

References

Marinsek M, Šuran D, Sinkovic A. Factors of Hospital Mortality in Men and Women with ST-Elevation Myocardial Infarction – An Observational, Retrospective, Single Centre Study. Int J Gen Med. 2023 Dec 18;16:5955-68. https://doi.org/10.2147/IJGM.S439414

Zwart B, Claessen BEPM, Damman P, Woudstra P, Vink MA, Balder JW, Dickinson MG, Badings EA, Appelman Y, van ‘t Hof AWJ, Ten Berg JM, Arslan F. 2023 European Society of Cardiology guidelines for the management of acute coronary syndromes : Statement of endorsement by the NVVC. Neth Heart J. 2024 Oct;32(10):338-45. https://doi.org/10.1007/s12471-024-01896-2

Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease. J Am Coll Cardiol. 2016 Jan 5;67(1):1-12. https://doi.org/10.1016/j.jacc.2015.10.044

Kirolos I, Yakoub D, Pendola F, Picado O, Kirolos A, Levine YC, et al. Cardiac physiology in post myocardial infarction patients: the effect of cardiac rehabilitation programs-a systematic review and update meta-analysis. Ann Transl Med. 2019:7:416. https://doi.org/10.21037/atm.2019.08.64

Wang XY, Ye ZH. Development of a middle-range theory of adaptation to chronic illness based on the Roy’s model. Chin J Nurs. 2021;56:1193-200. https://doi.org/10.3761/j.issn.0254-1769.2021.08.012

Schulz R, Andreadou, I, Ferdinandy P. PCSK9: Importance Physiology and Pathophysiology. Frontiers in Physiology. 2021;12:706115. https://doi.org/10.3389/fphys.2021.706115

Leander K, Mälarstig A, Van’t Hooft FM, Hyde C, Hellénius ML, Troutt JS, Konrad RJ, Öhrvik J, Hamsten A, de Faire U. Circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) predicts future risk of cardiovascular events independently of established risk factors. Circulation. 2016;133:1230-9. https://doi.org/10.1161/CIRCULATIONAHA.115.018531

Kamani CH, Gencer B, Monteccuco F. Eur J Clin Invest. 2015 Jun 17. https://doi.org/10.1111/eci.12480

Tirandi A, Liberale L. Physical activity to reduce PCSK9 levels. Front Cardiovasc Med. 25 Aug 2022; 9:2022 https://doi.org/10.3389/fcvm.2022.988698

Byrne R, Rossello X, Coughlan J, Barbato E, Berry C, Chieffo A, Claeys MJ, Gheorghe-Andrei Dan, Dweck MR, Galbraith M. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology. Eur Heart J. 7 Oct 2023;4(38):3720–826. https://doi.org/10.1093/eurheartj/ehad191

Piotrowicz R, Wolszakiewicz J. Cardiac rehabilitation following myocardial infarction. Cardiol J. 2008;15(5):481-7. https://pubmed.ncbi.nlm.nih.gov/18810728/

Ambrosetti M, Ana Abreu A, Corrà U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. J Prev Cardiol. 2021 May 14;28(5):460-95. https://doi.org/10.1177/2047487320913379

Doherty PJ, Harrison AS. The National Audit of Cardiac Rehabilitation: Annual Statistical Report [2017] 2017. https://www.researchgate.net/publication/328495382_The_National_Audit_of_Cardiac_Rehabilitation_Annual_Statistical_Report_2017

Zhang Z, Pack Q, Squires RW, Lopez-Jimenez F, Yu L, Thomas RJ. Availability and characteristics of cardiac rehabilitation programmes in China. Heart Asia. 2016;8:9-12. https://doi.org/10.1136/heartasia-2016-010758

Nesterak RV, Vakalyuk IP. Restorative treatment and rehabilitation of patients after acute coronary syndrome: scientific determinants and practical implementation. TERAPEVTYKA. 2021;2(1):5-10. https://doi.org/10.31793/2709-7404.2021.2-1.5

Dutcher JR, Kahn J, Grines C, Franklin B. Comparison of left ventricular ejection fraction and exercise capacity as predictors of two- and five-year mortality following acute myocardial infarction Am J Cardiol. 2007 Feb 15;99(4):436-41. https://doi.org/10.1016/j.amjcard.2006.08.053

Bayes-Genis A, Núñez J, Zannad F, Ferreira JP, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Metra M, Lupón J, Voors AA. The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis. J Am Coll Cardiol. 2017 Oct 24;70(17):2128-36. https://doi.org/10.1016/j.jacc.2017.08.057

Ekblom-Bak E, Halldin M, Vikstrom M, Stenling A, Gigante B, de Faire U, et al. Physical activity attenuates cardiovascular risk and mortality in men and women with and without the metabolic syndrome – a 20-year follow-up of a population-based cohort of 60-year-olds. Eur J Prev Cardiol. 2021;28:1376-85. https://doi.org/10.1177/2047487320916596

Warren JM, Ekelund U, Besson H, Mezzani A, Geladas N, Vanhees L; Experts Panel. Assessment of physical activity – a review of methodologies with reference to epidemiological research: a report of the exercise physiology section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010 Apr;17(2):127-39. https://doi.org/10.1097/HJR.0b013e32832ed875

Qiu C, Zhou Q, Li X, Zhang Z, Zeng P, Cao Z, Pan B, Li X, Chen AF. High circulating proprotein convertase subtilisin/Kexin type 9 concentration associates with cardiovascular risk: A meta-analysis of cohort studies. Medicine (Baltimore). 2017 Dec; 96(48):e8848. https://doi.org/10.1097/MD.0000000000008848.

Most read articles by the same author(s)

1 2 > >>